- Home
- Publications
- Publication Search
- Publication Details
Title
Perspectives on immunotherapy via oncolytic viruses
Authors
Keywords
Oncolytic virus, Oncolytic virotherapy, Cancer immunotherapy, Cancer gene therapy, Oncolytic HSV-1, Tumor microenvironment
Journal
Infectious Agents and Cancer
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-02-11
DOI
10.1186/s13027-018-0218-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Management of patients with acute promyelocytic leukemia
- (2018) Sabine Kayser et al. LEUKEMIA
- Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy
- (2018) Simona Soverini et al. Molecular Cancer
- Superagonist IL-15-armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 Blockade
- (2018) Stacy J. Kowalsky et al. MOLECULAR THERAPY
- Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic Efficacy
- (2018) Jacob M. Ricca et al. MOLECULAR THERAPY
- Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer Eradication
- (2018) Christopher C. Kloss et al. MOLECULAR THERAPY
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy
- (2018) Suman Bishnoi et al. Viruses-Basel
- The Requirement for Increasingly Effective Societal Cancer Control Efforts
- (2018) Maurie Markman Current Oncology Reports
- The Use of the Humanized Mouse Model in Gene Therapy and Immunotherapy for HIV and Cancer
- (2018) Mayra A. Carrillo et al. Frontiers in Immunology
- Tune Up In Situ Autovaccination against Solid Tumors with Oncolytic Viruses
- (2018) Teresa Nguyen et al. Cancers
- Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations
- (2018) Judith A. Seidel et al. Frontiers in Oncology
- Intratumor heterogeneity defines treatment-resistant HER2+ breast tumors
- (2018) Inga H. Rye et al. Molecular Oncology
- Going (Reo)Viral: Factors Promoting Successful Reoviral Oncolytic Infection
- (2018) Tarryn Bourhill et al. Viruses-Basel
- Novel Therapies in Acute Lymphoblastic Leukemia
- (2018) Kathleen W. Phelan et al. Current Hematologic Malignancy Reports
- A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumors
- (2018) Valerio Leoni et al. PLoS Pathogens
- Current status and perspectives of patient-derived xenograft models in cancer research
- (2017) Yunxin Lai et al. Journal of Hematology & Oncology
- Oncolytic viruses: emerging options for the treatment of breast cancer
- (2017) Yogesh R. Suryawanshi et al. MEDICAL ONCOLOGY
- A Comparative Safety Profile Assessment of Oncolytic Virus Therapy Based on Clinical Trials
- (2017) Takuma Matsuda et al. Therapeutic Innovation & Regulatory Science
- The Oncolytic Virotherapy Era in Cancer Management: Prospects of Applying H-1 Parvovirus to Treat Blood and Solid Cancers
- (2017) Assia L. Angelova et al. Frontiers in Oncology
- Targeting Nucleotide Biosynthesis: A Strategy for Improving the Oncolytic Potential of DNA Viruses
- (2017) Chad R. Irwin et al. Frontiers in Oncology
- Genetically Engineered Vaccinia Viruses As Agents for Cancer Treatment, Imaging, and Transgene Delivery
- (2017) Dana Haddad Frontiers in Oncology
- Systematic review of the use of granulocyte–macrophage colony-stimulating factor in patients with advanced melanoma
- (2016) Christoph Hoeller et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Oncolytic virus therapy: A new era of cancer treatment at dawn
- (2016) Hiroshi Fukuhara et al. CANCER SCIENCE
- Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma
- (2016) Igor Puzanov et al. JOURNAL OF CLINICAL ONCOLOGY
- An engineered avian-origin influenza A virus for pancreatic ductal adenocarcinoma virotherapy
- (2016) Matteo Samuele Pizzuto et al. JOURNAL OF GENERAL VIROLOGY
- MicroRNA-Detargeted Mengovirus for Oncolytic Virotherapy
- (2016) Autumn J. Ruiz et al. JOURNAL OF VIROLOGY
- Phase 1 Study of Intravenous Oncolytic Poxvirus (vvDD) in Patients With Advanced Solid Cancers
- (2016) Stephanie Downs-Canner et al. MOLECULAR THERAPY
- Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma
- (2016) Anne M Noonan et al. MOLECULAR THERAPY
- Retargeting Strategies for Oncolytic Herpes Simplex Viruses
- (2016) Gabriella Campadelli-Fiume et al. Viruses-Basel
- Measles to the Rescue: A Review of Oncolytic Measles Virus
- (2016) Sarah Aref et al. Viruses-Basel
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Progress in clinical oncolytic virus-based therapy for hepatocellular carcinoma
- (2015) Adel H. Jebar et al. JOURNAL OF GENERAL VIROLOGY
- Immunosuppressive cells in tumor immune escape and metastasis
- (2015) Yang Liu et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Hodgkin Lymphoma: Diagnosis and Treatment
- (2015) Stephen M. Ansell MAYO CLINIC PROCEEDINGS
- Oncolytic viruses: a new class of immunotherapy drugs
- (2015) Howard L. Kaufman et al. NATURE REVIEWS DRUG DISCOVERY
- IL-2: The First Effective Immunotherapy for Human Cancer
- (2014) S. A. Rosenberg JOURNAL OF IMMUNOLOGY
- Maraba MG1 Virus Enhances Natural Killer Cell Function via Conventional Dendritic Cells to Reduce Postoperative Metastatic Disease
- (2014) Jiqing Zhang et al. MOLECULAR THERAPY
- Dendritic-Cell-Based Therapeutic Cancer Vaccines
- (2013) Karolina Palucka et al. IMMUNITY
- Exploiting the curative potential of adoptive T-cell therapy for cancer
- (2013) Christian S. Hinrichs et al. IMMUNOLOGICAL REVIEWS
- Emerging Paradigms in the Development of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer
- (2013) Justin F. Gainor et al. JOURNAL OF CLINICAL ONCOLOGY
- The causes and consequences of genetic heterogeneity in cancer evolution
- (2013) Rebecca A. Burrell et al. NATURE
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- Oncolytic virotherapy
- (2012) Stephen J Russell et al. NATURE BIOTECHNOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started